Showing results (1-10 of 287) with videos related to
Sort By:
Pageof 29
Clinical Reviews in Allergy & Immunology|October 16, 2014
Gene replacement therapy for genetic hepatocellular jaundiceRemco van Dijk, Ulrich Beuers, Piter J BosmaScientific Reports|May 12, 2017
Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivoRemco van Dijk, Sem J Aronson, Dirk R de Waart, et al.Journal of Hepatology|July 30, 2015
Disruption of HNF1α binding site causes inherited severe unconjugated hyperbilirubinemiaRemco van Dijk, Isabel Mayayo-Peralta, Sem J Aronson, et al.Human Gene Therapy|September 10, 2013
Polyinosinic acid blocks adeno-associated virus macrophage endocytosis in vitro and enhances adeno-associated virus liver-directed gene therapy in vivoRemco van Dijk, Paula S Montenegro-Miranda, Christel Riviere, et al.Molecular Therapy. Methods & Clinical Development|July 9, 2020
A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 TransgeneSem J Aronson, Robert S Bakker, Sascha Moenis, et al.Digestive Diseases (Basel, Switzerland)|July 19, 2014
Advances in pathogenesis and management of pruritus in cholestasisAndreas E Kremer, Ruth Bolier, Remco van Dijk, et al.Biochimica Et Biophysica Acta|January 18, 2016
Enteroendocrine cells are a potential source of serum autotaxin in menRuth Bolier, Dagmar Tolenaars, Andreas E Kremer, et al.Current Gene Therapy|April 10, 2009
Towards liver-directed gene therapy for Crigler-Najjar syndromePaula S Montenegro Miranda, Piter J BosmaBiochimica Et Biophysica Acta|May 2, 2012
Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemiaPaula S Montenegro-Miranda, Nina Sneitz, D Rudi de Waart, et al.Nature Clinical Practice. Gastroenterology & Hepatology|June 3, 2006
Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasisUlrich BeuersPageof 29